{"schema_version":"secwatch.filing_event.v1","accession":"0001800943-23-000001","form_type":"8-K","ticker":"BRGX","cik":"0001593184","company_name":"BIOREGENX, INC.","filed_at":"2023-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.750380+00:00","generated_at":"2026-06-20T18:47:43.514668+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Findit enters definitive merger with BioRegenx; existing shareholders to hold 10% of voting stock","bullets":["BioRegenx shareholders will receive common and preferred shares equivalent to 90% of Findit's voting securities.","Findit Series A and B preferred shares (98.47% voting control) will be retired into treasury.","Both parties agree to implement up to a 1-for-25 reverse stock split post-merger.","Merger expected to close in Q1 2023, subject to shareholder and regulatory approvals.","Combined entity will be renamed BioRegenx, Inc. and apply for a new ticker symbol."],"urls":{"canonical":"https://secwatch.observer/filing/0001800943-23-000001","json":"https://secwatch.observer/filing/0001800943-23-000001.json","markdown":"https://secwatch.observer/filing/0001800943-23-000001.md","text":"https://secwatch.observer/filing/0001800943-23-000001.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1593184/000180094323000001/0001800943-23-000001-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1593184/000180094323000001/fdit8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T18:47:43.514668+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b229b76a4c0dc6f6d024ca26709df6571ad69c79","claim":"BIOREGENX, INC. entered into Merger Agreement with BioRegenx, Inc. (effective 2022-12-29).","evidence_excerpt":"On December 29, 2022, Findit, Inc. (the “Company” or “Findit”) announced it had entered into a definitive merger agreement (the “Merger Agreement”) with BioRegenx, Inc. (“BioRegenx”), a Nevada corporation.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1593184/000180094323000001/0001800943-23-000001-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"BioRegenx, Inc."},{"label":"Effective","value":"2022-12-29"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}